393 related articles for article (PubMed ID: 10986059)
1. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Mattano LA; Sather HN; Trigg ME; Nachman JB
J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
[TBL] [Abstract][Full Text] [Related]
2. Bony morbidity in children treated for acute lymphoblastic leukemia.
Strauss AJ; Su JT; Dalton VM; Gelber RD; Sallan SE; Silverman LB
J Clin Oncol; 2001 Jun; 19(12):3066-72. PubMed ID: 11408503
[TBL] [Abstract][Full Text] [Related]
3. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Levien MG
Clin Pediatr (Phila); 2002; 41(1):63-4. PubMed ID: 11866371
[No Abstract] [Full Text] [Related]
4. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia.
Elmantaser M; Stewart G; Young D; Duncan R; Gibson B; Ahmed SF
Arch Dis Child; 2010 Oct; 95(10):805-9. PubMed ID: 20576660
[TBL] [Abstract][Full Text] [Related]
5. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.
Mattano LA; Devidas M; Nachman JB; Sather HN; Hunger SP; Steinherz PG; Gaynon PS; Seibel NL;
Lancet Oncol; 2012 Sep; 13(9):906-15. PubMed ID: 22901620
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
Aricò M; Boccalatte MF; Silvestri D; Barisone E; Messina C; Chiesa R; Santoro N; Tamaro P; Lippi A; Gallisai D; Basso G; De Rossi G;
Haematologica; 2003 Jul; 88(7):747-53. PubMed ID: 12857552
[TBL] [Abstract][Full Text] [Related]
7. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
[TBL] [Abstract][Full Text] [Related]
8. Osteonecrosis in children with acute lymphoblastic leukemia: A report from Children's Cancer Hospital Egypt (CCHE).
Ali N; Gohar S; Zaky I; Elghoneimy A; Youssef S; Sameer G; Yassin D; Salem S; Magdi H; Sidhom I
Pediatr Blood Cancer; 2019 Jan; 66(1):e27440. PubMed ID: 30183135
[TBL] [Abstract][Full Text] [Related]
9. Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.
Mogensen SS; Harila-Saari A; Mäkitie O; Myrberg IH; Niinimäki R; Vestli A; Hafsteinsdottir S; Griškevicius L; Saks K; Hallböök H; Retpen J; Helt LR; Toft N; Schmiegelow K; Frandsen TL;
Pediatr Blood Cancer; 2018 Oct; 65(10):e27300. PubMed ID: 29943905
[TBL] [Abstract][Full Text] [Related]
10. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia.
Murphy RG; Greenberg ML
Cancer; 1990 Apr; 65(8):1717-21. PubMed ID: 2317754
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma.
Ribeiro RC; Fletcher BD; Kennedy W; Harrison PL; Neel MD; Kaste SC; Sandlund JT; Rubnitz JE; Razzouk BI; Relling MV; Pui CH
Leukemia; 2001 Jun; 15(6):891-7. PubMed ID: 11417473
[TBL] [Abstract][Full Text] [Related]
12. British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma.
Amin N; Kinsey S; Feltbower R; Kraft J; Whitehead E; Velangi M; James B
BMJ Open; 2019 May; 9(5):e027204. PubMed ID: 31122988
[TBL] [Abstract][Full Text] [Related]
13. Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution.
Chen SH; Chang TY; Jaing TH; Lee MS; Wang CJ; Hung IJ; Yang CP
Int J Hematol; 2015 Jul; 102(1):41-7. PubMed ID: 25840770
[TBL] [Abstract][Full Text] [Related]
14. Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Hyakuna N; Shimomura Y; Watanabe A; Taga T; Kikuta A; Matsushita T; Kogawa K; Kawakami C; Horikoshi Y; Iwai T; Okamoto Y; Tsurusawa M; Asami K;
J Pediatr Hematol Oncol; 2014 Jan; 36(1):22-9. PubMed ID: 24136019
[TBL] [Abstract][Full Text] [Related]
15. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME;
J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887
[TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis in paediatric patients with acute lymphoblastic leukaemia treated on Co-ALL-07-03 trial: a single centre analysis.
Kuhlen M; Moldovan A; Krull K; Meisel R; Borkhardt A
Klin Padiatr; 2014 May; 226(3):154-60. PubMed ID: 24710762
[TBL] [Abstract][Full Text] [Related]
17. Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
Sawicka-Zukowska M; Kajdas L; Muszynska-Roslan K; Krawczuk-Rybak M; Sonta-Jakimczyk D; Szczepanski T
Pediatr Hematol Oncol; 2006 Dec; 23(8):625-9. PubMed ID: 17065138
[TBL] [Abstract][Full Text] [Related]
18. Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL).
Padhye B; Dalla-Pozza L; Little D; Munns C
Cancer Med; 2016 May; 5(5):960-7. PubMed ID: 26792372
[TBL] [Abstract][Full Text] [Related]
19. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
J Clin Oncol; 2007 Apr; 25(12):1498-504. PubMed ID: 17442991
[TBL] [Abstract][Full Text] [Related]
20. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
Nachman J; Sather HN; Gaynon PS; Lukens JN; Wolff L; Trigg ME
J Clin Oncol; 1997 Jun; 15(6):2222-30. PubMed ID: 9196134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
